Champions Oncology (CSBR) Tops Q3 EPS by 37c

Champions Oncology (NASDAQ: CSBR) reported Q3 EPS of $0.36, $0.37 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $17 million versus the consensus estimate of $12.93 million.

For earnings history and earnings-related data on Champions Oncology (CSBR) click here.

You May Also Be Interested In

• Keefe, Bruyette & Woods Downgrades Bain Capital Specialty Finance (BCSF) to Market Perform
• Jefferies Downgrades Aegis Vopak Terminals (AEGISVOP:IN) to Hold
• ICICI Securities Starts Cemindia Projects (CEMPRO:IN) at Buy (1)